Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001144204-08-068933
Filing Date
2008-12-12
Accepted
2008-12-12 06:01:28
Documents
8
Period of Report
2008-10-30
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v134568_8k-a.htm 8-K/A 48702
2 v134568_ex15-1.htm EX-15.1 42685
3 v134568_ex15-2.htm EX-15.2 19141
4 v134568_ex16-1.htm EX-16.1 1001
5 GRAPHIC v134568_ex16-1x1x1.jpg GRAPHIC 35518
6 v134568_ex99-1.htm EX-99.1 194342
7 GRAPHIC logo.jpg GRAPHIC 1966
8 GRAPHIC signature.jpg GRAPHIC 2398
  Complete submission text file 0001144204-08-068933.txt   362842
Mailing Address 1635 VILLAGE CENTER CIRCLE SUITE 250 LAS VEGAS NV 89134
Business Address 1635 VILLAGE CENTER CIRCLE SUITE 250 LAS VEGAS NV 89134 702-248-1174
CardioVascular BioTherapeutics, Inc. (Filer) CIK: 0001303497 (see all company filings)

EIN.: 330795984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-51172 | Film No.: 081244793
SIC: 2834 Pharmaceutical Preparations